BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23827912)

  • 1. [Evaluation of a program of application of the botulinum toxin type A in children with cerebral palsy in Vale do Jequitinhonha].
    Silva GF; Teles MC; Santos SA; Ferreira FO; Almeida KM; Camargos AC
    Cien Saude Colet; 2013 Jul; 18(7):2075-84. PubMed ID: 23827912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
    Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
    Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression.
    Binay Safer V; Ozbudak Demir S; Ozkan E; Demircioglu Guneri F
    Neurosciences (Riyadh); 2016 Oct; 21(4):331-337. PubMed ID: 27744462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of shear wave elastography in the evaluation of muscle stiffness in patients with cerebral palsy after botulinum toxin A injection.
    Dağ N; Cerit MN; Şendur HN; Zinnuroğlu M; Muşmal BN; Cindil E; Oktar SÖ
    J Med Ultrason (2001); 2020 Oct; 47(4):609-615. PubMed ID: 32705628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
    Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
    Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
    Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
    J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
    Nguyen L; Mesterman R; Gorter JW
    BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A in children. New indication for limb spasticity.
    Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
    Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
    J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy.
    Fazzi E; Maraucci I; Torrielli S; Motta F; Lanzi G
    J Child Neurol; 2005 Aug; 20(8):661-6. PubMed ID: 16225811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
    Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin type A for the treatment of spasticity in children with cerebral palsy].
    Dimitrijević L; Stanković I; Zivković V; Mikov A; Colović H; Janković I
    Vojnosanit Pregl; 2007 Aug; 64(8):513-8. PubMed ID: 17874717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin Type A in the Spasticity of Cerebral Palsy Related to Congenital Zika Syndrome: An Observational Study.
    Armani-Franceschi G; Luz C; Lucena PH; d'Afonseca D; Sales H; Carvalho AL; Siqueira IC; Silva K; Portuense S; Monteiro L; Bandeira ID; Melo A; Lucena R
    Dev Neurorehabil; 2022 Apr; 25(3):162-169. PubMed ID: 34387523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
    J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.